18 April 2018

Dead should be assigned the value 0 in economic models combining survival and quality of life, such as the Quality Adjusted Life Years (QALY) model. This is a result found by researchers Bram Roudijk, Rogier Donders and Peep Stalmeier of the Department for Health Evidence and was published in Medical Decision Making on April 9th , 2018.

The considerations for setting dead at zero
The main reason for setting dead at zero is that in multiplicative models, there should be a health state for which one is indifferent to the duration of that health state. Only dead is a candidate to be this health state.

Effects on decision making
The position of dead needs to be carefully established, as it determines the relative importance of life-improving and life-saving treatments in the allocation of resources in health care.

Publication
Setting Dead at Zero: Applying Scale Properties to the QALY Model
Bram Roudijk, A. Rogier T. Donders, Peep F.M. Stalmeier

This research was conducted within the theme Healthcare improvement science.

Related news items


First BeNeFit funding granted for psoriasis

17 January 2020

RIHS researchers Elke de Jong and Juul van den Reek of Dermatology Radboudumc and Dermatology Ghent receive grant of 1.6 million euros for investigating dose reduction of the newest biologics for psoriasis.

read more

RIMLS award ceremony proudly presenting the winners

16 January 2020

Several RIMLS researchers received an award and bonus during the New Year's drinks. See all photo's and the ENABLE aftermovie.

read more

The PRIDE Study Evaluation of online methods of data collection

16 January 2020

In Paediatric and Perinatal Epidemiology RIHS researchers Marleen van Gelder and Nel Roeleveld described the recruitment methods and online data collection within the PRIDE Study, the largest Dutch birth cohort study.

read more

Laparoscopy reduces the number of adhesions but it is still too high

14 January 2020

Adhesions after abdominal surgery cause too many re-admissions. Although keyhole surgery reduces the number of adhesions and the complications associated with them, the total disease burden remains high, as reported in The Lancet by RIHS researcher Richard ten Broek and colleagues.

read more

Rubicon Grant for Marieke Klein

14 January 2020

DCMN researcher Marieke Klein, theme Neurodevelopmental disorders, received a Rubicon Grant from the Dutch Organisation for Scientific Research (NWO). The Rubicon program gives young, highly promising researchers the opportunity to gain international research experience.

read more

Radboud Talks 2020 scientific pitch competition

14 January 2020

The next edition of Radboud Talks will take place in the spring. During this academic pitch competition, young researchers will be given the opportunity to share their stories with a large audience. In a three-minute presentation, you will talk about your research in a fun and accessible manner.

read more